Cargando…

A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold

BACKGROUND: MMP-2 enzyme is a kind of matrix metalloproteinases that digests the denatured collagens and gelatins. It is highly involved in the process of tumor invasion and has been considered as a promising target for cancer therapy. The structural requirements of an MMP-2 inhibitor are: (1) a fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi, Maryam, Ramezani, Fatemeh, Elyasi, Maryam, Sadeghi-Aliabadi, Hojjat, Amanlou, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423142/
https://www.ncbi.nlm.nih.gov/pubmed/25925871
http://dx.doi.org/10.1186/s40199-015-0111-z
_version_ 1782370158453456896
author Abbasi, Maryam
Ramezani, Fatemeh
Elyasi, Maryam
Sadeghi-Aliabadi, Hojjat
Amanlou, Massoud
author_facet Abbasi, Maryam
Ramezani, Fatemeh
Elyasi, Maryam
Sadeghi-Aliabadi, Hojjat
Amanlou, Massoud
author_sort Abbasi, Maryam
collection PubMed
description BACKGROUND: MMP-2 enzyme is a kind of matrix metalloproteinases that digests the denatured collagens and gelatins. It is highly involved in the process of tumor invasion and has been considered as a promising target for cancer therapy. The structural requirements of an MMP-2 inhibitor are: (1) a functional group that binds the zinc ion, and (2) a functional group which interacts with the enzyme backbone and the side chains which undergo effective interactions with the enzyme subsites. METHODS: In the present study, a QSAR model was generated to screen new inhibitors of MMP-2 based on L–hydroxy tyrosine scaffold. Descriptors generation were done by Hyperchem 8, DRAGON and Gaussian98W programs. SPSS and MATLAB programs have been used for multiple linear regression (MLR) and genetic algorithm partial least squares (GA-PLS) analyses and for theoretical validation. Applicability domain of the model was performed to screen new compounds. The binding site potential of all inhibitors was verified by structure-based docking according to their binding energy and then the best inhibitors were selected. RESULTS: The best QSAR models in MLR and GA-PLS were reported, with the square correlation coefficient for leave-one-out cross-validation (Q(2)(LOO)) larger than 0.921 and 0.900 respectively. The created MLR and GA-PLS models indicated the importance of molecular size, degree of branching, flexibility, shape, three-dimensional coordination of different atoms in a molecule in inhibitory activities against MMP-2. The docking study indicated that lipophilic and hydrogen bonding interactions among the inhibitors and the receptor are involved in a ligand-receptor interaction. The oxygen of carbonyl and sulfonyl groups is important for hydrogen bonds of ligand with Leu82 and Ala83. R(2) and R(3) substituents play a main role in hydrogen bonding interactions. R(1) is sited in the hydrophobic pocket. Methylene group can help a ligand to be fitted in the lipophilic pocket, so two methylene groups are better than one. The Phenyl group can create a π-π interaction with Phe86. CONCLUSIONS: The QSAR and docking analyses demonstrated to be helpful tools in the prediction of anti-cancer activities and a guide to the synthesis of new metalloproteinase inhibitors based on L-tyrosine scaffold.
format Online
Article
Text
id pubmed-4423142
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44231422015-05-08 A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold Abbasi, Maryam Ramezani, Fatemeh Elyasi, Maryam Sadeghi-Aliabadi, Hojjat Amanlou, Massoud Daru Research Article BACKGROUND: MMP-2 enzyme is a kind of matrix metalloproteinases that digests the denatured collagens and gelatins. It is highly involved in the process of tumor invasion and has been considered as a promising target for cancer therapy. The structural requirements of an MMP-2 inhibitor are: (1) a functional group that binds the zinc ion, and (2) a functional group which interacts with the enzyme backbone and the side chains which undergo effective interactions with the enzyme subsites. METHODS: In the present study, a QSAR model was generated to screen new inhibitors of MMP-2 based on L–hydroxy tyrosine scaffold. Descriptors generation were done by Hyperchem 8, DRAGON and Gaussian98W programs. SPSS and MATLAB programs have been used for multiple linear regression (MLR) and genetic algorithm partial least squares (GA-PLS) analyses and for theoretical validation. Applicability domain of the model was performed to screen new compounds. The binding site potential of all inhibitors was verified by structure-based docking according to their binding energy and then the best inhibitors were selected. RESULTS: The best QSAR models in MLR and GA-PLS were reported, with the square correlation coefficient for leave-one-out cross-validation (Q(2)(LOO)) larger than 0.921 and 0.900 respectively. The created MLR and GA-PLS models indicated the importance of molecular size, degree of branching, flexibility, shape, three-dimensional coordination of different atoms in a molecule in inhibitory activities against MMP-2. The docking study indicated that lipophilic and hydrogen bonding interactions among the inhibitors and the receptor are involved in a ligand-receptor interaction. The oxygen of carbonyl and sulfonyl groups is important for hydrogen bonds of ligand with Leu82 and Ala83. R(2) and R(3) substituents play a main role in hydrogen bonding interactions. R(1) is sited in the hydrophobic pocket. Methylene group can help a ligand to be fitted in the lipophilic pocket, so two methylene groups are better than one. The Phenyl group can create a π-π interaction with Phe86. CONCLUSIONS: The QSAR and docking analyses demonstrated to be helpful tools in the prediction of anti-cancer activities and a guide to the synthesis of new metalloproteinase inhibitors based on L-tyrosine scaffold. BioMed Central 2015-04-29 /pmc/articles/PMC4423142/ /pubmed/25925871 http://dx.doi.org/10.1186/s40199-015-0111-z Text en © Abbasi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Abbasi, Maryam
Ramezani, Fatemeh
Elyasi, Maryam
Sadeghi-Aliabadi, Hojjat
Amanlou, Massoud
A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
title A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
title_full A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
title_fullStr A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
title_full_unstemmed A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
title_short A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
title_sort study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on l-tyrosine scaffold
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423142/
https://www.ncbi.nlm.nih.gov/pubmed/25925871
http://dx.doi.org/10.1186/s40199-015-0111-z
work_keys_str_mv AT abbasimaryam astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT ramezanifatemeh astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT elyasimaryam astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT sadeghialiabadihojjat astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT amanloumassoud astudyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT abbasimaryam studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT ramezanifatemeh studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT elyasimaryam studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT sadeghialiabadihojjat studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold
AT amanloumassoud studyonquantitativestructureactivityrelationshipandmoleculardockingofmetalloproteinaseinhibitorsbasedonltyrosinescaffold